Search through
Ambroxol Hydrochloride is a mucolytic agent that facilitates the clearance of mucus from the respiratory tract. It is commonly used in the treatment of respiratory diseases such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Ambroxol works by breaking down the structure of mucus, making it easier to expel. AMBROXOL is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications. Other identifiers such UNII 200168S0CL and QH6ZT6J071.
Ambroxol Hydrochloride is a mucolytic agent that facilitates the clearance of mucus from the respiratory tract. It is commonly used in the treatment of respiratory diseases such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Ambroxol works by breaking down the structure of mucus, making it easier to expel. AMBROXOL is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications. Other identifiers such UNII 200168S0CL and QH6ZT6J071.
Chemical Properties & Specifications
Eye Irritation: Category 2A Skin Irritation: Category 2
H319: Causes serious eye irritation. H315: Causes skin irritation.
P264: Wash hands thoroughly after handling. P280: Wear protective gloves and eye protection. P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing. P302+P352: IF ON SKIN: Wash with plenty of water.
Used as an active ingredient in formulations for treating respiratory conditions by reducing mucus viscosity.
Incorporated into over-the-counter and prescription medications aimed at alleviating productive coughs.
Store at room temperature (15–30°C) in tightly sealed, light-resistant containers, protected from moisture and contaminants.
Keep in a cool, dry, and well-ventilated area, away from direct sunlight and moisture.
Use appropriate containers to prevent environmental contamination.
Available in 1 kg, 5 kg, 10 kg, and 25 kg containers. Custom packaging solutions are available upon request.
Ambroxol Intermediates are used in the synthesis of Ambroxol Hydrochloride, a widely prescribed mucolytic agent for respiratory conditions such as bronchitis, asthma, and COPD.
Ambroxol acts by breaking down mucus in the lungs, reducing its viscosity, and enhancing mucus clearance to facilitate easier breathing.
High demand is observed in North America, Europe, and Southeast Asia, where Ambroxol is extensively used in respiratory treatments
Manufacturers must comply with pharmacopeial standards such as IP, BP, and USP, ensuring Good Manufacturing Practices (GMP) and regulatory approvals for pharmaceutical applications.
Yes, Ambroxol is commonly formulated with bronchodilators and antihistamines in multi-ingredient respiratory medications.
Yes, Ambroxol Intermediates comply with global standards, including REACH, USP, EP/BP, and GMP-certified manufacturing processes.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...
